Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure

Primary breast diffuse large B‐cell lymphoma (PB‐DLBCL) is a rare subtype of DLBCL with limited data on patterns of failure. This multicenter study aimed to define the optimum treatment strategy and patterns of failure for PB‐DLBCL patients. We retrospectively reviewed data on 108 PB‐DLBCL patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shaoxuan, Song, Yuqin, Sun, Xiuhua, Su, Liping, Zhang, Wei, Jia, Jing, Bai, Ou, Yang, Sheng, Liang, Rong, Li, Xiaoling, Zhang, Huilai, Gao, Yuhuan, Zhang, Weijing, Xiao, Xiubin, Bao, Huizheng, Wang, Ningju, Ren, Hanyun, Cen, Xinan, Yang, Shun'e, Zhao, Yu, Wang, Yinan, Wang, Yalan, Liu, Aichun, Wang, Jingwen, Shi, Yuankai, Yuan, Ming, Li, Yufu, He, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272095/
https://www.ncbi.nlm.nih.gov/pubmed/30302857
http://dx.doi.org/10.1111/cas.13828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272095/
https://www.ncbi.nlm.nih.gov/pubmed/30302857
http://dx.doi.org/10.1111/cas.13828

Ejemplares similares